Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04916990 · ClinicalTrials.gov registry record · NA

Improving Care for Rural Patients With Solid Tumors

A NA study of Breast Cancer and Lung Cancer, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
320
Enrollment target
14
Study locations

NCT04916990: Recruiting NA study of Breast Cancer and Lung Cancer, sponsored by University of Colorado, Denver.

NCT04916990 is a NA study of Breast Cancer and Lung Cancer that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 320 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower). The trial reports 14 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04916990, a NA study of Breast Cancer and Lung Cancer, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
320 participants
Enrollment target
14
Study locations

Study Summary

This study will assess if the CARES (Cancer Advocacy, Resources, Education and Support) intervention improves time to start of treatment after diagnosis and time to treatment completion for solid tumors (ex: lung, head, neck, thyroid, cervical, breast, bladder, colon, and rectal cancers) in rural patients.

Primary Outcome

Number of days from diagnosis to treatment initiation and number of days from treatment initiation to treatment completion

Interventions

  • BEHAVIORAL CARES Intervention

Study Locations (14)

Colorado

  • University of Colorado Hospital - Aurora
  • Memorial Hospital Central - Colorado Springs
  • Memorial Hospital North - Colorado Springs
  • Poudre Valley Hospital - Fort Collins
  • SCL- St. Mary's Medical Center - Grand Junction
  • VA Western Colorado Health Care System - Grand Junction
  • Greeley Campus - Greeley
  • Highlands Ranch Hospital - Highlands Ranch
  • Medical Center of the Rockies - Loveland
  • San Juan Cancer Center - Montrose
  • Rocky Mountain Cancer Center - Pueblo
  • UCHealth - Parkview medical Center - Pueblo
  • Yampa Valley Medical Center - Steamboat Springs

Utah

  • Huntsman Cancer Institute at the University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2022-09-01
Est. Completion 2027-06-30
Phase NA
University of Colorado, Denver

1,283 total trials

What NCT04916990 shows while recruiting

NCT04916990 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (89% lower).

The record links to 8 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which CARES Intervention is the first listed.

NCT04916990 lists 14 locations in 2 states (Colorado, Utah).

Frequently Asked Questions

What is clinical trial NCT04916990 about?

NCT04916990 is a clinical study titled "Improving Care for Rural Patients With Solid Tumors". This study will assess if the CARES (Cancer Advocacy, Resources, Education and Support) intervention improves time to start of treatment after diagnosis and time to treatment completion for solid tumors (ex: lung, head, neck, thyroid, cervical, breast, bladder, colon, and rectal cancers) in rural pa...

What is the current status of trial NCT04916990?

This trial is currently recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2022-09-01. Estimated completion is 2027-06-30.

What conditions does trial NCT04916990 study?

This clinical trial studies the following conditions: Breast Cancer, Lung Cancer, Head and Neck Cancer, Bladder Cancer, Cervical Cancer.

What interventions are being tested in trial NCT04916990?

The interventions under investigation include: CARES Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04916990?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04916990 being conducted?

This trial has 14 study locations across Colorado, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04916990's enrollment target sits among peer trials

320 267th of 1224 higher than 957 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02763683 · 320 participants

    Investigations of Dementia in Parkinson Disease

  • NCT03331198 · 320 participants · Phase 1

    Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

  • NCT03458832 · 320 participants

    Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

  • NCT03551951 · 320 participants

    Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04916990, the US trial registry maintained by the National Library of Medicine. NCT04916990 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.